Market Cap | 308.51M | P/E | - | EPS this Y | 11.90% | Ern Qtrly Grth | - |
Income | -86.28M | Forward P/E | -3.16 | EPS next Y | 5.00% | 50D Avg Chg | 7.00% |
Sales | 16.66M | PEG | 0.12 | EPS past 5Y | - | 200D Avg Chg | -2.00% |
Dividend | N/A | Price/Book | 0.71 | EPS next 5Y | -11.70% | 52W High Chg | -64.00% |
Recommedations | 2.70 | Quick Ratio | 24.42 | Shares Outstanding | 60.73M | 52W Low Chg | 58.00% |
Insider Own | 7.25% | ROA | -13.99% | Shares Float | 46.94M | Beta | 1.65 |
Inst Own | 71.52% | ROE | -20.45% | Shares Shorted/Prior | 2.76M/2.35M | Price | 4.84 |
Gross Margin | 51.05% | Profit Margin | - | Avg. Volume | 257,946 | Target Price | 7.00 |
Oper. Margin | -500.95% | Earnings Date | May 7 | Volume | 95,431 | Change | -0.21% |
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Morgan Stanley | Equal-Weight | Feb 21, 23 |
B of A Securities | Underperform | Jan 4, 23 |
Morgan Stanley | Equal-Weight | Nov 10, 22 |
Morgan Stanley | Equal-Weight | Aug 11, 22 |
JP Morgan | Neutral | Aug 11, 22 |
Morgan Stanley | Equal-Weight | May 5, 22 |
Morgan Stanley | Equal-Weight | Mar 1, 22 |
Morgan Stanley | Equal-Weight | Feb 15, 22 |
Morgan Stanley | Equal-Weight | Aug 13, 21 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Farokhzad Omid | CEO, President and C.. CEO, President and Chair | Aug 23 | Buy | 2.4492 | 40,000 | 97,968 | 807,744 | 08/24/23 |
Farokhzad Omid | CEO, President and C.. CEO, President and Chair | Feb 21 | Sell | 4.1337 | 13,840 | 57,210 | 767,744 | 02/22/23 |
Horn David R. | Chief Financial Offi.. Chief Financial Officer | Feb 07 | Sell | 5.3972 | 3,124 | 16,861 | 267,716 | 02/08/23 |
Farokhzad Omid | CEO, President and C.. CEO, President and Chair | Feb 07 | Sell | 4.6698 | 8,379 | 39,128 | 379,584 | 02/08/23 |
Farokhzad Omid | CEO, President and C.. CEO, President and Chair | Jan 17 | Sell | 5.1194 | 4,800 | 24,573 | 387,963 | 02/08/23 |
Horn David R. | Chief Financial Offi.. Chief Financial Officer | Jan 17 | Sell | 5.1193 | 2,602 | 13,320 | 270,840 | 01/19/23 |
Horn David R. | Chief Financial Offi.. Chief Financial Officer | Dec 07 | Sell | 6.5701 | 18,884 | 124,070 | 273,442 | 12/08/22 |
Farokhzad Omid | CEO, President and C.. CEO, President and Chair | Nov 08 | Option | 0.04 | 59,171 | 2,367 | 392,763 | 11/09/22 |
Kogan Elona Esq. | General Counsel and.. General Counsel and Secretary | Jun 08 | Sell | 8.9094 | 8,185 | 72,923 | 101,370 | 06/10/22 |
OSTADAN OMEAD | President & COO President & COO | May 27 | Sell | 8.06 | 4,441 | 35,794 | 378,238 | 06/01/22 |
OSTADAN OMEAD | President & COO President & COO | Apr 20 | Sell | 10.1828 | 52,042 | 529,933 | 384,080 | 04/22/22 |
Horn David R. | Chief Financial Offi.. Chief Financial Officer | Feb 02 | Sell | 17.40 | 2,944 | 51,226 | 229,158 | 02/04/22 |
OSTADAN OMEAD | President & COO President & COO | Dec 15 | Option | 2.7 | 20,000 | 54,000 | 397,448 | 12/16/21 |
OSTADAN OMEAD | President & COO President & COO | Dec 15 | Sell | 23.28 | 20,000 | 465,600 | 377,448 | 12/16/21 |
Horn David R. | Chief Financial Offi.. Chief Financial Officer | Dec 06 | Option | 3.47 | 28,818 | 99,998 | 234,410 | 12/08/21 |
Horn David R. | Chief Financial Offi.. Chief Financial Officer | Dec 06 | Sell | 20.26 | 26,273 | 532,291 | 205,592 | 12/08/21 |
OSTADAN OMEAD | President & COO President & COO | Oct 15 | Option | 2.7 | 20,000 | 54,000 | 397,448 | 10/19/21 |
OSTADAN OMEAD | President & COO President & COO | Oct 15 | Sell | 32.94 | 20,000 | 658,800 | 377,448 | 10/19/21 |